Oxidative stress and its downstream signaling in aging eyes

Clinical Interventions in Aging

Volumn 9, Issue , 2014, Pages 637-652

  Pinazo Durán, María Dolores ^a   Gallego Pinazo, Roberto ^b   García Medina, Jose Javier ^a,c   Zanón Moreno, Vicente ^a,d   Nucci, Carlo ^e   Dolz Marco, Rosa ^b   Martínez Castillo, Sebastián ^b   Galbis Estrada, Carmen ^a   Marco Ramírez, Carla ^a   López Gálvez, Maria Isabel ^f   Galarreta, David J ^f   Díaz Llópis, Manuel ^d  

^a Ophthalmic Research Unit Santiago Grisolia   (Spain)

^b HOSPITAL UNIVERSITARIO LA FE   (Spain)

^c HOSPITAL GENERAL UNIVERSITARIO REINA SOFÍA   (Spain)

^d UNIVERSITY OF VALENCIA   (Spain)

^e UNIVERSITY OF ROME TOR VERGATA   (Italy)

^f UNIVERSITY OF VALLADOLID   (Spain)

Author keywords

Aging; Antioxidants; Epidemiology; Eyes; Ophthalmic diseases; Oxidative stress

Indexed keywords

CATALASE; CHELATING AGENT; GLUTATHIONE PEROXIDASE; REACTIVE OXYGEN METABOLITE; SCAVENGER; SUPEROXIDE DISMUTASE; TRANSITION ELEMENT;

AGING; ANTERIOR EYE SEGMENT; ARTICLE; BLEEDING; BLINDNESS; CANCER MORTALITY; CANCER RISK; CLINICAL EFFECTIVENESS; DIABETIC RETINOPATHY; DIET SUPPLEMENTATION; DRY EYE; EYE DISEASE; GLAUCOMA; HEART FAILURE; HIGH RISK PATIENT; HUMAN; INTRACELLULAR SIGNALING; LIPID PEROXIDATION; LIVER TOXICITY; MEDITERRANEAN DIET; MOLECULAR PATHOLOGY; NONHUMAN; NUTRITIONAL STATUS; NUTRITIONAL VALUE; OXIDATIVE STRESS; PATIENT SAFETY; PHAGOCYTOSIS; POSTERIOR EYE SEGMENT; PROTEIN FUNCTION; QUALITY OF LIFE; RETINA MACULA AGE RELATED DEGENERATION; RETINITIS PIGMENTOSA; RISK ASSESSMENT; RISK REDUCTION; VISUAL IMPAIRMENT; AGED; EYE; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; RETINA DISEASE; VISUAL SYSTEM FUNCTION;

AGED; AGING; DIETARY SUPPLEMENTS; DRY EYE SYNDROMES; EYE; GLAUCOMA; HUMANS; OCULAR PHYSIOLOGICAL PHENOMENA; OXIDATIVE STRESS; RETINAL DISEASES;

EID: 84898643104     PISSN: 11769092     EISSN: 11781998     Source Type: Journal    
DOI: 10.2147/CIA.S52662     Document Type: Article

References (135)

1. Krebs HA. Some aspects of the regulation of fuel supply in omnivorous animals. Adv Enzyme Regul. 1972;10:397-420.
2. Cheeseman KH, Slater TF. An introduction to free radical biochemistry. Br Med Bull. 1993;49:481-493.
3. Haber F, Weiss J. Über die Katalyse des Hydroperoxydes [On the catalysis of hydroperoxides]. Naturwissenschaften. 1932;20:948-950.
4. Fenton HJ. The oxidation of tartaric acid in presence of iron. J Chem Soc Trans. 1894;65:899-910.
5. Goldstein S, Meyerstein D, Czapski G. The Fenton reagents. Free Radic Biol Med. 1993;15:435-445.
6. Ames BN, Shigenaga MK. Oxidants are a major contributor to aging. Ann N Y Acad Sci. 1992;663:85-96.
7. Sies H. Oxidative stress: introductory remarks. In: Sies H, editor. Oxidative Stress. London: Academic Press; 1985:1-7.
8. D'Autréaux B, Toledano MB. ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis. Nat Rev Mol Cell Biol. 2007;8:813-824.
9. Halliwell B. Free radicals and antioxidants: updating a personal view. Nutr Rev. 2012;70:257-265.
10. McCord JM, Fridovich I. Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J Biol Chem. 1969;244:6049-6055.
11. Harman D. Ageing: a theory based on free radical and radiation chemistry. J Gerontol. 1956;2:298-300.
12. Gerschman R, Fenn W. Ascorbic acid content of adrenal glands of rat in oxygen poisoning. Am J Physiol. 1952;176:6-8.
13. Gerschman R, Nadig PW, Snell AC, Nye SW. Effect of high oxygen concentrations on eyes of newborn mice. Am J Physiol. 1954;179: 639-639.
14. Gerschman R, Gilbert DL, Nye SW, Fenn W. Influence of x-irradiation on oxygen poisoning in mice. Proc Soc Exp Biol Med. 1954;86: 27-29.
15. Agil A, Durán R, Barrero F, et al. Plasma lipid peroxidation in sporadic Parkinson's. Role of the L-dopa. J Neurol Sci. 2006;240:31-36.
16. Choi J, Sullards MC, Olzmann JA, et al. Oxidative damage of DJ-1 is linked to sporadic Parkinson and Alzheimer diseases. J Biol Chem. 2006;281:10816-10824.
17. Alaluf S, Muir-Howie H, Hu HL, Evans A, Green MR. Atmospheric oxygen accelerates the induction of a post-mitotic phenotype in human dermal fibroblasts: the key protective role of glutathione. Differentiation. 2000;66:147-155.
18. Alexandrova M, Bochev P, Markova V, et al. Dynamics of free radical processes in acute ischemic stroke: influence on neurological status and outcome. J Clin Neurosci. 2004;11:501-506.
19. Ames BN, Shigenaga MK, Hagen TM. Oxidants, antioxidants and degenerative diseases of aging. Proc Natl Acad Sci U S A. 1993;90: 7915-7922.
20. Conner EM, Grisham MB. Inflammation, free radicals, and antioxidants. Nutrition. 1996;12:274-277.
21. Williams DL. Oxidative stress and the eye. Vet Clin North Am Small Anim Pract. 2008;38:179-192.
22. Spector A. Oxidative stress-induced cataract: mechanism of action. FASEB J. 1995;9:1173-1182.
23. Zanon-Moreno V, Marco-Ventura P, Lleo-Perez A, et al. Oxidative stress in primary open angle glaucoma. J Glaucoma. 2008;17:263-268.
24. Pinazo-Durán MD, Azorin I, Montoliu C, Guerri C, Renau-Piqueras J. Free radicals are involved in the alcoholic optic neuropathy. Alcohol Clin Exp Res. 1998;22:A84.
25. Mancino R, Di Pierro D, Varesi C, et al. Lipid peroxidation and total antioxidant capacity in vitreous, aqueous humor, and blood samples from patients with diabetic retinopathy. Mol Vis. 2011;17:1298-1304.
26. Melo P, Zanon-Moreno V, Alves CJ, et al. Oxidative stress response in the adult rat retina and plasma after repeated administration of methamphetamine. Neurochem Int. 2010;56:431-436.
27. Beatty S, Koh H, Phil M, Henson D, Boulton M. The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol. 2000;45:115-134.
28. Margrain TH, Boulton M, Marshall J, Sliney DH. Do blue light filters confer protection against age-related macular degeneration? Prog Retin Eye Res. 2004;23:523-531.
29. Rahman K. Studies on free radicals, antioxidants and co-factors. Clin Interv Aging. 2007;2:219-236.
30. Carocho M, Ferreira IC. A review on antioxidants, prooxidants and related controversy: natural and synthetic compounds, screening and analysis methodologies and future perspectives. Food Chem Toxicol. 2013;51:15-25.
31. Birben E, Sahiner UM, Sackesen C, Erzurum S, Kalayci O. Oxidative stress and antioxidant defense. World Allergy Organ J. 2012;5: 9-19.
32. Doly M, Droy-Lefaix MT, Braquet P. Oxidative stress in diabetic retina. EXS. 1992;62:299-307.
33. Yadav UC, Kalariya NM, Ramana KV. Emerging role of antioxidants in the protection of uveitis complications. Curr Med Chem. 2011;18: 931-942.
34. Prashar S, Pandav SS, Gupta A, Nath R. Antioxidant enzymes in RBCs as a biological index of age related macular degeneration. Acta Ophthalmol (Copenh). 1993;71:214-218.
35. Perry HD. Dry eye disease: pathophysiology, classification, and diagnosis. Am J Manag Care. 2008;14:S79-S87.
36. Tavares FP, Fernandes RS, Bernardes TF, Bonfioli AA, Soares EJ. Dry eye disease. Semin Ophthalmol. 2010;25:84-93.
37. Labbé A, Brignole-Baudouin F, Baudouin C. [Ocular surface investigations in dry eye]. J Fr Ophtalmol. 2007;30:76-97. French.
38. Schein OD, Muñoz B, Tielsch JM, Bandeen-Roche K, West S. Prevalence of dry eye among the elderly. Am J Ophthalmol. 1997;124: 723-728.
39. Muñoz B, West SK, Rubin GS, et al. Causes of blindness and visual impairment in a population of older Americans: the Salisbury Eye Evaluation Study. Arch Ophthalmol. 2000;118:819-825.
40. Moss SE, Klein R, Klein BE. Long-term incidence of dry eye in an older population. Optom Vis Sci. 2008;85:668-674.
41. Schaumberg DA, Sullivan DA, Buring JE, Dana MR. Prevalence of dry eye syndrome among US women. Am J Ophthalmol. 2003;136: 318-326.
42. Gipson IK, Spurr-Michaud S, Argüeso P, Tisdale A, Ng TF, Russo CL. Mucin gene expression in immortalized human corneal-limbal and conjunctival epithelial cell lines. Invest Ophthalmol Vis Sci. 2003;44: 2496-2506.
43. Zuclich JA, Connolly JS. Ocular damage induced by near-ultraviolet laser radiation. Invest Ophthalmol Vis Sci. 1976;15:760-764.
44. Higuchi A, Takahashi K, Hirashima M, Kawakita T, Tsubota K. Selenoprotein P controls oxidative stress in cornea. PLoS One. 2010;5:e9911.
45. Uchino Y, Kawakita T, Ishii T, Ishii N, Tsubota K. A new mouse model of dry eye disease: oxidative stress affects functional decline in the lacrimal gland. Cornea. 2012;31 Suppl 1:S63-S67.
46. Nakamura S, Shibuya M, Nakashima H, et al. Involvement of oxidative stress on corneal epithelial alterations in a blink-suppressed dry eye. Invest Ophthalmol Vis Sci. 2007;48:1552-1558.
47. VanDerMeid KR, Su SP, Krenzer KL, Ward KW, Zhang JZ. A method to extract cytokines and matrix metalloproteinases from Schirmer strips and analyze using Luminex. Mol Vis. 2011;17:1056-1063.
48. Enríquez-de-Salamanca A, Castellanos E, Stern ME, et al. Tear cytokine and chemokine analysis and clinical correlations in evaporative-type dry eye disease. Mol Vis. 2010;16:862-873.
49. Baudouin C, Brignole F, Becquet F, Pisella PJ, Goguel A. Flow cytometry in impression cytology specimens. A new method for evaluation of conjunctival inflammation. Invest Ophthalmol Vis Sci. 1997;38: 1458-1464.
50. Pinazo-Durán MD, Galbis-Estrada C, Pons-Vázquez S, Cantú-Dibildox J, Marco-Ramírez C, Benítez-del-Castillo J. Effects of a nutraceutical formulation based on the combination of antioxidants and ω-3 essential fatty acids in the expression of inflammation and immune response mediators in tears from patients with dry eye disorders. Clin Interv Aging. 2013;8:139-148.
51. Galbis-Estrada C, Pinazo-Durán MD, Cantú-Dibildox J, Marco-Ramírez C, Diaz-Llopis M, Benítez-del-Castillo J. Patients undergoing antihypertensive treatment with antihypertensive eye drops responded positively with respect to their ocular surface disorder to oral supplementation with antioxidants and essential fatty acids. Clin Interv Aging. 2013;8:711-719.
52. Tsubota K, Kawashima M, Inaba T, et al. The antiaging approach for the treatment of dry eye. Cornea. 2012;31 Suppl 1:S3-S8.
53. Weinreb RN, Khaw PT. Primary open-angle glaucoma. Lancet. 2004;363:1711-1720.
54. Osborne NN, Wood JP, Chidlow G, Bae JH, Melena J, Nash MS. Ganglion cell death in glaucoma: what do we really know? Br J Ophthalmol. 1999;83:980-986.
55. Huang W, Dobberfuhl A, Filippopoulos T, et al. Transcriptional up-regulation and activation of initiating caspases in experimental glaucoma. Am J Pathol. 2005;167:673-681.
56. Pinazo-Durán MD, Gallego-Pinazo R, Zanón-Moreno V, Serrano M. Glaucoma genetics - regulation of cell surviving and death in the retina. In: Rumelkt S, editor. Glaucoma: Basic and Clinical Concepts. Rijeka, Croatia: InTech; 2011:207-224.
57. Saccà SC, Izzotti A. Oxidative stress and glaucoma: injury in the anterior segment of the eye. Prog Brain Res. 2008;173:385-407.
58. Tezel G. Oxidative stress in glaucomatous neurodegeneration: mechanisms and consequences. Prog Retin Eye Res. 2006;25:490-513.
59. Pinazo-Durán MD, Zanón-Moreno V, García-Medina JJ, Gallego-Pinazo R. Evaluation of presumptive biomarkers of oxidative stress, immune response and apoptosis in primary open-angle glaucoma. Curr Opin Ophthalmol. 2013;13:98-107.
60. Bazan NG. Survival signaling in retinal pigment epithelial cells in response to oxidative stress: significance in retinal degenerations. Adv Exp Med Biol. 2006;572:531-540.
61. Kennedy CJ, Rakoczy PE, Constable IJ. Lipofuscin of the retinal pigment epithelium: a review. Eye (Lond). 1995;9:763-771.
62. Cai J, Nelson KC, Wu M, Sternberg P Jr, Jones DP. Oxidative damage and protection of the RPE. Prog Retin Eye Res. 2000;19:205-221.
63. Mukherjee PK, Marcheselli VL, Serhan CN, Bazan NG. Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress. Proc Natl Acad Sci U S A. 2004;101:8491-8496.
64. Bazan NG. Neuroprotectin D1 (NPD1): a DHA-derived mediator that protects brain and retina against cell injury-induced oxidative stress. Brain Pathol. 2005;15:159-166.
65. Calandria JM, Mukherjee PK, de Rivero Vaccari JC, Zhu M, Petasis NA, Bazan NG. Ataxin-1 poly(Q)-induced proteotoxic stress and apoptosis are attenuated in neural cells by docosahexaenoic acid-derived neuroprotectin D1. J Biol Chem. 2012;287:23726-23739.
66. Klein R, Peto T, Bird A, Vannewkirk MR. The epidemiology of age related macular degeneration. Am J Ophthalmol. 2004;137: 486-495.
67. Curcio CA, Johnson M, Rudolf M, Huang JD. The oil spill in ageing Bruch membrane. Br J Ophthalmol. 2011;95:1638-1645.
68. Faghir Z, Bazan NG. PI3K/Akt and mTOR/p70S6K pathways mediate neuroprotectin D1-induced retinal pigment epithelial cell survival during oxidative stress-induced apoptosis. Exp Eye Res. 2010;90:718-725.
69. Klettner A. Oxidative stress induced cellular signaling in RPE cells. Front Biosci (Schol Ed). 2012;4:392-411.
70. Koenekoop R. The gene for Stargardt disease, ABCA4, is a major retinal gene: a mini-review. Ophthalmic Genet. 2003;24:75-80.
71. Nowak JZ. Oxidative stress, polyunsaturated fatty acids-derived oxidation products and bisretinoids as potential inducers of CNS diseases: focus on age-related macular degeneration. Pharmacol Rep. 2013;65:288-304.
72. Castilho A, Aveleira CA, Leal EC, et al. Heme oxygenase-1 protects retinal endothelial cells against high glucose- and oxidative/nitrosative stress-induced toxicity. PLoS One. 2012;7:e42428.
73. Sparrow JR, Zhou J, Ben-Shabat S, Vollmer H, Itagaki Y, Nakanishi K. Involvement of oxidative mechanisms in blue-light-induced damage to A2E-laden RPE. Invest Ophthalmol Vis Sci. 2002;43(4):1222-1227.
74. Maleki S, Gopalakrishnan S, Ghanian Z, et al. Optical imaging of mitochondrial redox state in rodent model of retinitis pigmentosa. J Biomed Opt. 2013;18:16004.
75. Zhuo Y, Luo H, Zhang K. Leber hereditary optic neuropathy and oxidative stress. Proc Natl Acad Sci U S A. 2012;109:19882-19883.
76. Pinazo-Durán MD, Verdejo C, Azorín I, Renau-Piqueras J, Iborra FJ. Colocalization of aldehyde dehydrogenases and Fe/NADPH-induced lipid peroxidation in tissue sections of rat retina. Ophthalmic Res. 2000;32:61-68.
77. Galbis-Estrada C, Pons-Vázquez S, Gallego-Pinazo R, et al. Glutathione-dependent formaldehyde dehydrogenase (ADH3) and low km mitochondrial aldehyde dehydrogenase (ALDH2). New evidence for differential expression in the rat retina in response to oxidative stress. Free Radic Res. 2012;46:77-84.
78. Rogers BS, Symons RC, Komeima K, et al. Differential sensitivity of cones to iron-mediated oxidative damage. Invest Ophthalmol Vis Sci. 2007;48:438-445.
79. Dentchev T, Hahn P, Dunaief JL. Strong labeling for iron and the iron-handling proteins ferritin and ferroportin in the photoreceptor layer in age-related macular degeneration. Arch Ophthalmol. 2005;123: 1745-1746.
80. He X, Hahn P, Iacovelli J, et al. Iron homeostasis and toxicity in retinal degeneration. Prog Retin Eye Res. 2007;26:649-673.
81. Song D, Song Y, Hadziahmetovic M, Zhong Y, Dunaief JL. Systemic administration of the iron chelator deferiprone protects against light-induced photoreceptor degeneration in the mouse retina. Free Radic Biol Med. 2012;53:64-71.
82. Arden GB, Sivaprasad S. Hypoxia and oxidative stress in the causation of diabetic retinopathy. Curr Diabetes Rev. 2011;7:291-304.
83. Son SM. Role of vascular reactive oxygen species in development of vascular abnormalities in diabetes. Diabetes Res Clin Pract. 2006; 77 Suppl 1:S65-S70.
84. Gupta MM, Chari S. Lipid peroxidation and antioxidant status in patients with diabetic retinopathy. Indian J Physiol Pharmacol. 2005;49: 187-192.
85. Verdejo C, Marco P, Renau-Piqueras J, Pinazo-Duran MD. Lipid peroxidation in proliferative vitreoretinopathies. Eye (Lond). 1999;13: 183-188.
86. Robison WG Jr, Jacot JL, Katz ML, Glover JP. Retinal vascular changes induced by the oxidative stress of alpha-tocopherol deficiency contrasted with diabetic microangiopathy. J Ocul Pharmacol Ther. 2000;16:109-120.
87. Martín-Gallán P, Carrascosa A, Gussinyé M, Domínguez C. Biomarkers of diabetes-associated oxidative stress and antioxidant status in young diabetic patients with or without subclinical complications. Free Radic Biol Med. 2003;34:1563-1574.
88. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazuz M, Telsen J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol. 2007;39:44-84.
89. Pácal L, Varvařovská J, Rušavý Z, et al. Parameters of oxidative stress, DNA damage and DNA repair in type 1 and type 2 diabetes mellitus. Arch Physiol Biochem. 2011;117:222-230.
90. Dolinoy DC, Huang D, Jirtle RL. Maternal nutrient supplementation counteracts bisphenol A-induced DNA hypomethylation in early development. Proc Natl Acad Sci U S A. 2007;104:13056-13061.
91. US Department of Health and Human Services. Dietary guidelines for Americans, 2010. Available from: http://www.dietaryguidelines.gov. Accessed December 19, 2013.
92. Keys A, Menotti A, Karvonen MJ, et al. The diet and 15-year death rate in the seven countries study. Am J Epidemiol. 1986;124:903-915.
93. Keys A. Mediterranean diet and public health: personal reflections. Am J Clin Nutr. 1995;61:1321S-1323S.
94. Sofi F, Cesari F, Abbate R, Gensini GF, Casini A. Adherence to Mediterranean diet and health status: meta-analysis. BMJ. 2008;377: a1344.
95. Serra-Majem L, Roman B, Estruch R. Scientific evidence of interventions using the Mediterranean diet: a systematic review. Nutr Rev. 2006;64:S27-S47.
96. Delcourt C, Korobelik JF, Barberger-Gateau P, et al. Nutrition and age-related eye diseases: the ALIENOR (Antioxydants, LIpides Essentiels, Nutrition et Maladies OculaiRes) study. J Nutr Health Aging. 2009;14:854-861.
97. Malet F, Le Goff M, Colin J, et al. Dry eye disease in French elderly subjects: the Alienor Study. Acta Ophthalmol. Epub June 7, 2013.
98. Quaranta L, Bettelli S, Uva MG, Semeraro F, Turano R, Gandolfo E. Effect of Ginkgo biloba extract on preexisting visual field damage in normal tension glaucoma. Ophthalmology. 2003;110:2:359-362.
99. Ritch R. Potential role for Ginko biloba extract in the treatment of glaucoma. Med Hypotheses. 2000;54:221-235.
100. Coleman AL, Stone KL, Kodjebacheva G, et al. Glaucoma risk and the consumption of fruits and vegetables among older women in the study of osteoporotic fractures. Am J Ophthalmol. 2008;145:1081-1089.
101. Kang JH, Pasquale LR, Willett WC, et al. Dietary fat consumption and primary open-angle glaucoma. Am Soc Clin Nutr. 2004;79: 5755-5764.
102. Zanon-Moreno V, Asensio-Marquez EM, Ciancotti-Oliver L, et al. Effects of polymorphisms in vitamin E-, vitamin C-, and glutathione peroxidase-related genes on serum biomarkers and associations with glaucoma. Mol Vis. 2013;19:231-242.
103. Zanon-Moreno V, Ciancotti-Olivares L, Asencio J, et al. Association between a SLC23A2 gene variation, plasma vitamin C levels, and risk of glaucoma in a Mediterranean population. Mol Vis. 2011;17: 2997-3004.
104. VandenLangenberg GM, Mares-Perlman JA, Klein R, Klein BE, Brady WE, Palta M. Associations between antioxidant and zinc intake and the 5-year incidence of early age-related maculopathy in the Beaver Dam Eye Study. Am J Epidemiol. 1998;148:204-214.
105. Van Leeuwen R, Boekhoorn S, Vingerling JR, et al. Dietary intake of antioxidants and risk of age-related macular degeneration. JAMA. 2005;294:3101-3107.
106. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no 8. Arch Ophthalmol. 2001;119:1417-1436.
107. Connor KM, SanGiovanni JP, Lofqvist C, et al. Increased dietary intake of omega-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis. Nat Med. 2007;13:868-873.
108. Seddon JM, George S, Rosner B. Cigarette smoking, fish consumption, omega-3 fatty acid intake, and associations with age-related macular degeneration: the US Twin Study of Age-Related Macular Degeneration. Arch Ophthalmol. 2006;124:995-1001.
109. SanGiovanni JP, Chew EY, Agrón E, et al. The relationship of dietary omega-3 long-chain polyunsaturated fatty acid intake with incident age-related macular degeneration. AREDS report no. 23. Arch Ophthalmol. 2008;126:1274-1279.
110. Krinsky NI, Landrum JT, Bone RA. Biologic mechanisms of the protective role of lutein and zeaxanthin in the eye. Annu Rev Nutr. 2003;23:171-201.
111. Semba RD, Dagnelie G. Are lutein and zeaxanthin conditionally essential nutrients for eye health? Med Hypotheses. 2003;61:465-472.
112. Schweigert FJ, Reimann J. [Micronutrients and their relevance for the eye - function of lutein, zeaxanthin and omega-3 fatty acids]. Klin Monbl Augenheilkd. 2011;228:537-543. German.
113. Moeller SM, Parekh N, Tinker L, et al. Associations between intermediate age-related macular degeneration and lutein and zeaxanthin in the Carotenoids in Age-Related Eye Disease study (CAREDS): ancillary study of the Women's Health Initiative. Arch Ophthalmol. 2006;124:1151-1162.
114. Tan JS, Wang JJ, Flood V, Rochtchina E, Smith W, Mitchell P. Dietary antioxidants and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study. Ophthalmology. 2008;115:334-341.
115. Age-Related Eye Disease Study Research Group, San Giovanni JP, Chew EY, et al. The relationship of dietary carotenoid and vitamin A, E, and C intake with age-related macular degeneration in a case control study: AREDS report no 22. Arch Ophthalmol. 2007;125: 1225-1232.
116. Seddon JM, Ajani UA, Sperduto RD, et al. Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group. JAMA. 1994;272:1413-1420.
117. Delcourt C, Cristol JP, Tessier F, Léger CL, Descomps B, Papoz L. Age-related macular degeneration and antioxidant status in the POLA study. POLA Study Group. Pathologies Oculaires Liées à l'Age. Arch Ophthalmol. 1999;117:1384-1390.
118. Mares-Perlman JA, Fisher AI, Klein R, et al. Lutein and zeaxanthin in the diet and serum and their relation to age-related maculopathy in the third national health and nutrition examination survey. Am J Epidemiol. 2001;153:424-432.
119. Richer S, Stiles W, Statkute L. Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: the Veterans LAST study (Lutein Antioxidant Supplementation Trial). Optometry. 2004;75:216-230.
120. Age-Related Eye Disease Study 2 Research Group. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. JAMA. 2013;309:2005-2015.
121. Mayer-Davis EJ, Bell RA, Reboussin BA, Rushing J, Marshall JA, Hamman RF. Antioxidant nutrient intake and diabetic retinopathy: the San Luis Valley Diabetes Study. Ophthalmology. 1998;105: 2264-2270.
122. Weiner DE, Tighiouart H, Reynolds R, Seddon JM. Kidney function, albuminuria and age-related macular degeneration in NHANES III. Nephrol Dial Transplant. 2011;26:3159-3165.
123. [No authors listed]. Diabetes Control and Complications Trial (DCCT): results of feasibility study. The DCCT Research Group. Diabetes Care. 1987;10:1-19.
124. Millen AE, Gruber M, Klein R, Klein BE, Palta M, Mares JA. Relations of serum ascorbic acid and alpha-tocopherol to diabetic retinopathy in the Third National Health and Nutrition Examination Survey. Am J Epidemiol. 2003;158:225-233.
125. Roy S, Khanna S, Alessio HM, et al. Anti-angiogenic property of edible berries. Free Radic Res. 2002;36:9:1023-1031.
126. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 2011;414:813-820.
127. Garcia-Medina JJ, Pinazo-Duran MD, Garcia-Medina M, Zanon-Moreno V, Pons-Vazquez S. A 5-year follow-up of antioxidant supplementation in type 2 diabetic retinopathy. Eur J Ophthalmol. 2011;21:637-643.
128. Lonn E, Bosch J, Yusuf S, et al. Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA. 2005;293:1338-1347.
129. Rodríguez-Castilla V, Cuadrado C, Pozo S, Moreiras O. Concentraciones plasmáticas de carotenos y vitaminas antioxidantes en personas de edad avanzada: influencia del tabaquismo. Proyecto HALE [Plasmatic concentrations of carotenoids and antioxidant vitamins in elder people: influence of smoking. Hale Project]. Clin Investig Arterioscler. 2005;17:101-111.
130. [No authors listed]. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. The Alpha Tocopherol, Beta Carotene Cancer Prevention Study Group. N Engl J Med. 1994;330:1029-1035.
131. Omenn GS, Goodman GE, Thornquist MD, et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med. 1996;334:1150-1155.
132. Fosmire GJ. Zinc toxicity. Am J Clin Nutr. 1990;51:225-227.
133. Block KI, Koch AC, Mead MN, Tothy PK, Newman RA, Gyllenhaal C. Impact of antioxidant supplementation on chemotherapeutic toxicity: a systematic review of the evidence from randomized controlled trials. Int J Cancer. 2008;15;123:1227-1239.
134. Selman C, McLaren JS, Collins AR, Duthie GG, Speakman JR. Deleterious consequences of antioxidant supplementation on lifespan in a wild-derived mammal. Biol Lett. 2013;9:1-5.
135. Food and Nutrition Board, Institute of Medicine. Copper. Dietary reference intakes for vitamin A, vitamin K, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc. Washington, D.C.: National Academy Press; 2001:224-257.